Get started
Author

Éva Somogyiné Ezer

Observed names: E. Somogyine Ezer, Ezer, Eva Somogyine, Éva Ezer
OpenAlex ID: A5009053305
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019 · Luis Paz-Ares, Mikhail Dvorkin, et al. · The Lancet · 2,281
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
2020 · Jonathan W Goldman, Mikhail Dvorkin, et al. · The Lancet Oncology · 688
Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control
2022 · János G. Pitter, Mariann Moizs, et al. · PLoS ONE · 12
Addition of epidermal growth factor receptor inhibitors to standard chemotherapy increases survival of advanced head and neck squamous cell carcinoma patients: A systematic review and meta‐analysis
2022 · Fruzsina Kiss, Krisztina Pohóczky, et al. · Oral Diseases · 7
PDF
The Combination of Single-Cell and Next-Generation Sequencing Can Reveal Mosaicism for BRCA2 Mutations and the Fine Molecular Details of Tumorigenesis
2021 · Alexandra Gráf, Márton Zsolt Enyedi, et al. · Cancers · 6
PDF
Dynamic MR Based Analysis of Tumor Movement in Upper and Mid Lobe Localized Lung Cancer
2008 · A. Kovacs, J. Hadjiev, et al. · Pathology & Oncology Research · 6
[Linac-based stereotactic ablative radiotherapy for pancreatic cancer with intrafractional triggered imaging].
2021 · Katalin Kisiván, Dóra Erdélyesi, et al. · PubMed · 1
Author response for "Addition of epidermal growth factor receptor inhibitors to standard chemotherapy increases survival of advanced head and neck squamous cell carcinoma patients: A systematic review and meta-analysis"
2022 · Kiss, Fruzsina, Pohoczky, Krisztina, et al.
PH-0433 DIBH SABR for abdominal tumors while monitoring with fiducial markers and triggered images
2021 · K. Kisivan, C. Glavak, et al. · Radiotherapy and Oncology
Works count: 9
Citation count: 2,998
H-index: 6
I10-index: 3
Year
Topic
Type